1 of 2
Story summary
- A California jury ordered Apple Inc. to pay Masimo Corp. $634 million for infringing Masimo Corp.'s pulse oximetry patent tied to Apple Watch oxygen monitoring.
- The jury found Apple Inc. violated all four claims; Masimo says Apple Watch is a patient monitor.
- Apple plans to appeal, arguing the patent expired in 2022 and covers outdated technology.
- The ruling comes as the U.S. International Trade Commission weighs Apple Watch import bans.
1 / 2
